Trials / Completed
CompletedNCT01571063
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters. * Trial with medicinal product
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 | Vitamin D3, 2.100 IU/d p.o. |
| DRUG | Placebo | Placebo Tbl. p.o. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2012-04-04
- Last updated
- 2016-10-25
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01571063. Inclusion in this directory is not an endorsement.